ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 179 filers reported holding ARCUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 18 | -99.4% | 0.00% | – |
| Q1 2023 | $54,000 | -86.7% | 2,987 | -84.7% | 0.00% | – |
| Q4 2022 | $405,000 | +0.2% | 19,559 | +26.4% | 0.00% | – |
| Q3 2022 | $404,000 | +3266.7% | 15,479 | +2959.1% | 0.00% | – |
| Q2 2022 | $12,000 | -86.4% | 506 | -81.7% | 0.00% | – |
| Q1 2022 | $88,000 | -71.1% | 2,772 | -63.1% | 0.00% | – |
| Q4 2021 | $305,000 | +258.8% | 7,515 | +142.3% | 0.00% | – |
| Q2 2021 | $85,000 | +214.8% | 3,102 | +217.2% | 0.00% | – |
| Q1 2021 | $27,000 | +2600.0% | 978 | +1239.7% | 0.00% | – |
| Q3 2020 | $1,000 | -66.7% | 73 | -18.0% | 0.00% | – |
| Q2 2020 | $3,000 | +50.0% | 89 | -45.7% | 0.00% | – |
| Q1 2020 | $2,000 | -93.9% | 164 | -95.1% | 0.00% | – |
| Q4 2019 | $33,000 | +43.5% | 3,322 | +33.5% | 0.00% | – |
| Q3 2019 | $23,000 | +76.9% | 2,489 | +55.6% | 0.00% | – |
| Q2 2019 | $13,000 | +8.3% | 1,600 | +60.0% | 0.00% | – |
| Q1 2019 | $12,000 | +9.1% | 1,000 | 0.0% | 0.00% | – |
| Q4 2018 | $11,000 | -42.1% | 1,000 | -26.6% | 0.00% | – |
| Q3 2018 | $19,000 | – | 1,362 | +6710.0% | 0.00% | – |
| Q2 2018 | $0 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |